AbelsonD.: Diagnostic value of the penile pulse and blood pressure: a Doppler study of impotence in diabetics. J. Urol., 113; 636 (1975).
2.
AndersenJ. T., BrandleyW. E.: Early detection of diabetic visceral neuropathy. Diabetes, 25; 1100 (1976).
3.
BelgranoE., TrombettaC., De RosaA. F., PittalugaP., GibertiC., RicciottiG.: Erezione farmacologicamente indotta: aspetti diagnostici. Sessuologia (in corso di stampa).
4.
BelgranoE., TrombettaC., BuzzoP.: Intracavernous papaverine as a diagnostic and therapeutic method in diabetic impotence. Abstract. Book «Second world meeting on impotence», Praga 1986.
5.
BrausteinG. D.: Endocrine causes of impotence. Optimistic outlook for restoration of potency. Postgrad. Med., 74; 207 (1983).
6.
BrindleyG. S.: Cavernous alfa blockade: a new tecnique for investigating and treating erectile impotence. Brit. J. Psichiatr., 143; 332–337 (1983).
7.
CampbellI. W., McCullochD. K.: Marital problems in diabetics. Practitioner, 223; 343–347 (1979).
8.
ChioderaP., LegrosJ. J.: Il n'y a pas de relation entre la libération d'insuline lors de l'iperglicémie provoquée et différents paramètres androgéniques chez des patients souffrant d'impuissance érective et d'intollerance au glucose. Acta Psych. Belg., 80; 494–504 (1980).
EllembergM.: Impotence in diabetes: the neurologic factor. Ann. Intern. Med., 75; 213–219 (1971).
16.
EllembergM.: Sexual function in diabetic patients. Ann. Intern. Med., 92 (part. 2); 331–333 (1980).
17.
EngelG., BurnhamS. J., CarterM. F.: Penile blood pressure in evaluation of erectile impotence. Fertil. & Steril., 30; 687–690 (1979).
18.
EwingD. J., CampbellI. W., ClarkeB. B.: The natural history of diabetic autonomic neuropaty. Quart. J. Med., 193; 95–108 (1980).
19.
FaermanI., ClocerL., FoxD., JadzinskyM. N., RappaportM.: Histological studies of the autonomic nervous fibers of the corpora cavernosa in impotent diabetic males. Diabetes, 23; 971–976 (1974).
20.
FairburnC. G., WuF. C. W., McCullochD. K., BorsayD. Q., EwingD. J., ClarkB. B., BancroftJ. H. J.: The clinical features of impotence: a preliminary study. Brit. J. Psych., 140; 447–452 (1982).
21.
FicherM.: Do endocrines play an aetiological role in diabetic and non diabetic sexual disfunctions? J. Androl., 5; 8–16 (1984).
22.
FurlowW. L.: Diagnosis and treatment of male erectile failure. Diabetes Care, 2; 18–25 (1979).
23.
GaskellP.: The importance of penile blood pressure in cases of impotence. Canad. Med. Assoc. J., 105; 1047–1051 (1971).
24.
GeisthorelW., NiedegeskeU., MorgnerK. D., WillmsB., MitakatH. J.: Impotence and diabetes. Medizinische Klinik, 70; 1417–1423 (1975).
GreeneL. F., DelalisP. P.: J. Urol., 98; 693–696 (1968).
27.
KarakanI.: Diagnosis of erectile impotence in diabetes mellitus: an objective and specific method. Ann. Intern. Med., 92 (part. 2); 334–337 (1980).
28.
KarakanI., WareJ. C., DevrentB., AltinelA., ThoenbyJ. I., WilliamsR. L., KayaN., ScottF. B.: Rem-sleep monitoring and NPT test in diabetic impotence. Sleep, 1; 125–132 (1978).
29.
KleyH. K., DeselaersT., PeerenboomH., KruskemperH. L.: Enhanced conversion of androstenedione to estrogenes in obese males. J. Clin. Endocr. Metab., 51; 1128–1132 (1980).
30.
KolodnyR. C., MastersW. H., JonsonsonV. E.: Textbook of sexual medicine.Little Brown, Boston1979.
31.
LegrosJ. J., DaubresseJ. C.: Impuissance sexuelle et troubles du métabolisme glucidique. Diabète & Métabolisme, 7; 135–144 (1981).
32.
LehmanT. P.: Etiology of diabetic impotence. J. Urol., 129; 291–294 (1983).
33.
MastersW., JohnsonV.: Human sexual inadequacy. Édition française: «Les mésententes sexuelles».R. Laffont, Paris1970.
34.
McCullochD. K., CampbellI. W., WuF. C., PrescottR. J., ClarkeB. E.: The prevalence of diabetic impotence. Diabetologia, 26; 437–440 (1984).
35.
McCullochD. K., YoungR. J., PrescottR. J., CampbellI. W., ClarkeB. F.: The natural history of the impotence in diabetic men. Diabetologia, 26; 437–440 (1984).
36.
MelmanA., HenryD. P., FeitenD. L., O'ConnorB. L.: Alteration of the penile corpora in patients with erectile impotence. Invest. Urol., 17; 474–477 (1980).
37.
MichalV.: Arterial disease as a cause of impotence. Clin. Endocr. Metab., 11; 725–748 (1982).
38.
MichalV., KramerR., PospichalJ., HejhalL.: Direct arterial anastomosis to the cavernous body in the treatment of erectile impotence. Rorhl. Chir., 52; 587 (1973).
39.
MichalV., KramarR., PospichalJ.: Femoropudendal by-pass, internal iliac tromboendoarterectomy and direct arterial anastomosis to the cavernous body in the treatment of erectile impotence. Bull. Soc. Chir., 33; 343 (1973).
40.
PazG., HommonnaiZ. I., AyslonD., CordovaT., KraicerP. F.: Immuno-active insuline in serum and seminal plasma of diabetic and non diabetic men and its role in the regulation of spermatozoal activity. Fertil. & Steril., 28; 836–840 (1977).
41.
PazG., HommonnaiZ. I., DrasminN., SoterA., KaplanR., KraicerP. F.: Fertility of the streptozocin-diabetic male rat. Andrologia, 10; 127–136 (1978).
42.
RenshawD. C.: Sexual function and diabetes. Psicosomatics, 20; 54–60 (1979).
43.
RivardD. J.: Anatomy, phisiology, and neurophisiology of male sexual function. In: BennetD. H.: «Management of male impotence».Williams & Wilkins, Baltimore1982.
44.
SchiaviR. C.: Psicological treatment of erectile disorders in diabetic patients. Ann. Intern. Med., 92 (part. 2); 337–339 (1980).
45.
ShiraiM., NakamuraM.: Diagnostic discrimination between organical and functional impotence by radioisotope penogram with 99mTc O4. Tohoku J. Exp. Med., 116; 9–15 (1975).
46.
StacklW., BucherA.: Intracavernous injection of Phenoxibenzamine for erectile disfunction. Proc. I World Meeting on Impotence. Parigi 1984.
47.
SchofflingK., FederlinK., DitschuneitH.: Disorders of sexual function in male diabetis. Diabetes, 12; 519–527 (1963).
48.
SudkvistG., LiljaB.: Autonomic neuropaty in diabetes mellitus: a follow-up study. Diabetes Care, 8; 129–134 (1985).
49.
TchobroutskyG.: Relation of diabetic control to development of microvascular complication. Diabetologia, 15; 143–152 (1978).
50.
TrombettaC., BuzzoP., DipedeE., BelgranoE.: La farmacoerezione diagnostica e terapeutica nei soggetti diabetici con deficit di erezione. Urologia (in corso di stampa).
51.
ViragF.: Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure. Angiology, 79; 87 (1984).
52.
ViragR., BouillyP., DanielC., ViragH.: Intracavernous injection of papaverine and other vasoactive drugs: a new era in the diagnosis and treatment of impotence. Proc. I World Meeting on Impotence, Parigi 1984.
53.
WagnerG., GreenR.: Impotence.Plenum Press, New York1983.
54.
ZorgniottiA. W., RossiG.: Vasculogenic impotence. Proc. I International Conference on Corpus Cavernosum Revascularization.Charles C. Thomas Publ., Springfield, Illinois, U.S.A., 1980.